ATRA
Atara Biotherapeutics Inc
8.60$
-4.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | 277.8% | 55.9% | 424.7% | 103.7% | 16.3% | 17.6% | |
| – | – | – | – | – | – | -277.8% | 100.0% | -324.7% | -3.7% | 83.7% | 82.4% | |
| – | – | – | – | – | – | 6,887.7% | 1,386.4% | 428.7% | 2,622.0% | 117.5% | 31.0% | |
| – | – | – | – | – | – | 1,813.1% | 387.4% | 107.2% | 593.8% | 30.9% | 21.7% | |
| – | – | – | – | – | – | 8,700.8% | 1,773.9% | 116.6% | 3,215.8% | 148.4% | 52.7% | |
| – | – | – | – | – | – | -8,700.8% | -1,673.9% | -441.2% | -3,219.5% | -64.7% | 29.7% | |
| – | – | – | – | – | – | 303.5% | 47.7% | 0.6% | 61.6% | 3.6% | 3.1% | |
| – | – | – | – | – | – | -8,631.9% | -1,672.1% | -359.1% | -3,220.7% | -66.2% | 27.1% | |
| – | – | – | – | – | – | 0.4% | 0.2% | 0.0% | 0.2% | 0.0% | 0.0% | |
| – | – | – | – | – | – | -8,632.3% | -1,672.3% | -359.1% | -3,220.9% | -66.2% | 27.1% | |
| – | – | – | – | – | – | -8,466.2% | -1,627.9% | -349.6% | -3,102.7% | -58.7% | 32.0% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.